According to a report in FierceBiotech, surprising news came out of the recently completed 45th Annual Meeting of the Drug Information Association (DIA). Despite cutbacks in the international biopharma industry, clinical trial activity was up in 2008. Overall, 795 new clinical trials were launched...
For most of the last decade, Wisconsin has been told it should be more like Minnesota. In many ways, that’s true. Minnesota has more college graduates, more business start-ups, more venture capital and, not surprisingly, higher per capita income than its neighbor to the east. Of...
As China has continued to grow as a major contender in the world economy, the Chinese have become more aware of the need to strengthen their system for intellectual property rights (IPR). Chinese patent law was first promulgated in 1984 and soon thereafter China became...
Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...
Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...
“Jumping the shark” is an expression that was coined by radio newscaster Jon Hein to capture the fact that a TV series has hit its peak and is in decline. I use this analogy to question whether the BIO organization has “jumped the shark” with...
“They do not have anything that could reach here, or do they?” questions James Carlini. The threat of nuclear bombs is such a remote possibility today that no one really thinks about it anymore. Or do they? According to the nuke-o-meter there are 8187...
In a meeting with the Detroit Free Press last October, then-presidential candidate Barack Obama said, "China has consistently stolen our intellectual property. It has not abided by basic copyright protections." Let's hope the president reminds the U.S. climate change team of those words before negotiations...
Lithium-Ion technology can be used on a more personal level. It is becoming more well-known that Lithium-Ion technology is being used for next-generation cars but there are applications on a more personal level which the average consumer may be able to use in powering...
The opponents of nuclear energy in the United States were almost giddy earlier this year when President Obama slashed the budget for a proposed waste storage site in Nevada. Surely, they thought, the inevitable demise of the Yucca Mountain project would end silly talk of...